Home | Welcome to Contract Pharma   
Last Updated Tuesday, September 23 2014
Print

Search Results for 'Kristin Brooks'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

CRO Outlook & Market Trends
By Kristin Brooks, Contract Pharma
Published June 5, 2013
Innovation tied to globalization & collaboration Read More »
Contract Pharma Team
Published February 28, 2011
Contract Pharma Team President, Rodman J. Zilenziger, Jr. Rodman J. Zilenziger Jr. — President of Rodman Media since 1993. Zilenziger, son of the Company’s founder, joined Rodman Media as an Advertising Representa… Read More »
Agile Drug Development
By Kristin Brooks , Contract Pharma
Published May 1, 2014
New business models and analytics are driving increased value and efficiency in CRO-sponsor partnerships Read More »
Joe Principe on the Patheon/DSM Merger
By Kristin Brooks
Published April 15, 2014
Patheon’s business development director discusses the formation of DPX with DSM, and how it melds two cultures. Read More »
Packaging Equipment & Trends
By Kristin Brooks , Contract Pharma
Published March 7, 2014
Serialization and robotics integration gains momentum Read More »
By Kristin Brooks
Published March 4, 2014
Opens corporate headquarters and R&D facility Read More »
Top 10 Biopharma Companies
By Gil Y. Roth, Editor
Published July 18, 2012
Our annual look at the 10 biggest players in the Biopharmaceutical marketplace Read More »
Top 20 Pharma Report
By Gil Y. Roth, Editor
Published July 18, 2012
Our annual look at the 20 biggest players in the Pharmaceutical marketplace Read More »
Published February 27, 2012
Refers to the physico-chemical condition of a parenteral or biological, or the shelf life of other drugs. A compound or pharmaceutical formulation is said to be stable if it is not reactive under certain conditions such as temperature, humidity, ligh… Read More »
2009 Top 20 Pharmaceutical Companies Report
Published July 15, 2009
They don’t call them “Big Pharma” for nothing! Several of the industry’s biggest players decided to get bigger via M&A this year, which means next year’s ranks are going to feature at least three new players, once Wyeth and Schering-Plough are swallowed up and Roche moves over to the Top Biopharma ranks. And I do mean top! Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On